Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Naoki Hasegawa and Koichi Fukunaga.
Connection Strength

0.794
  1. Control of a Nosocomial Outbreak of COVID-19 in a University Hospital. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa512.
    View in: PubMed
    Score: 0.227
  2. Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. Medicine (Baltimore). 2020 Aug 28; 99(35):e21804.
    View in: PubMed
    Score: 0.225
  3. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease. Clin Exp Rheumatol. 2021 May-Jun; 39(3):631-638.
    View in: PubMed
    Score: 0.059
  4. The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia. Respir Investig. 2021 May; 59(3):360-363.
    View in: PubMed
    Score: 0.058
  5. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2. J Clin Pathol. 2021 01; 74(1):67-68.
    View in: PubMed
    Score: 0.056
  6. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study. J Infect. 2020 11; 81(5):e3-e5.
    View in: PubMed
    Score: 0.056
  7. Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus. Ann Rheum Dis. 2021 05; 80(5):e77.
    View in: PubMed
    Score: 0.056
  8. Acute onset olfactory/taste disorders are associated with a high viral burden in mild or asymptomatic SARS-CoV-2 infections. Int J Infect Dis. 2020 Oct; 99:19-22.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.